Clinics in Dermatology
Volume 26, Issue 5 , Pages 464-476 , September 2008

Phototherapy and photochemotherapy

References 

  1. Diffey BL, Farr PM. An appraisal of ultraviolet lamps used for the phototherapy of psoriasis. Br J Dermatol. 1987;117:49–56
  2. Parrish JA. Ultraviolet phototherapy of psoriasis. Pharmacol Ther. 1981;15:313–320
  3. Honigsmann H. Phototherapy for psoriasis. Clin Exp Dermatol. 2001;26:343–350
  4. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974;291:1207–1211
  5. Wolff K, Honigsmann H, Gschnait F, Konrad K. [Photochemotherapy of psoriasis: clinical experiences with 152 patients (author's transl)]. Dtsch Med Wochenschr 1975;100:2471-7, 1497.
  6. Saraceno R, Griffiths CE. A European perspective on the challenges of managing psoriasis. J Am Acad Dermatol. 2006;54(3 Suppl 2):S81–S84
  7. Soderlin M, Blomkvist C, Dahl P, Forsberg P, Fohlman J. Increased risk of infection with biological immunomodifying antirheumatic agents. Clear guidelines are necessary as shown by case reports. Lakartidningen 2005;102:3794-6, 3799-800.
  8. Fischer T, Alsins J. Treatment of psoriasis with trioxsalen baths and dysprosium lamps. Acta Derm Venereol. 1976;56:383–390
  9. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76:359–362
  10. Zanolli M. Phototherapy treatment of psoriasis today. J Am Acad Dermatol. 2003;49(2 Suppl):S78–S86
  11. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol. 1992;127:5–9
  12. Taylor DK, Anstey AV, Coleman AJ, et al. Guidelines for dosimetry and calibration in ultraviolet radiation therapy: a report of a British Photodermatology Group workshop. Br J Dermatol. 2002;146:755–763
  13. Fukuyama K, Epstein WL, Epstein JH. Effect of ultraviolet light on RNA and protein synthesis in differentiated epidermal cells. Nature. 1967;216:1031–1032
  14. Epstein JH, Fukuyama K, Reed WB, Epstein WL. Defect in DNA synthesis in skin of patients with xeroderma pigmentosum demonstrated in vivo. Science. 1970;168:1477–1478
  15. Staberg B. Psoriasis. Transcapillary and interstitial transport of plasma proteins, cutaneous blood, flow, and effect of phototherapy. Dan Med Bull. 1985;32:295–308
  16. Dawe RS, Ferguson J. History of psoriasis response to sunlight does not predict outcome of UVB phototherapy. Clin Exp Dermatol. 2004;29:413–414
  17. Gibbs NK. Narrowband UV-B phototherapy clears psoriasis through a combination of local and systemic effects. Arch Dermatol. 2003;139:665;[author reply 665-6]
  18. Baden HP, Parrington JM, Delhanty JD, Pathak MA. DNA synthesis in normal and xeroderma pigmentosum fibroblasts following treatment with 8-methoxypsoralen and long wave ultraviolet light. Biochim Biophys Acta. 1972;262:247–255
  19. Walter JF, Kelsey WH, Voorhees JJ, Duell EA. Psoralen plus black light inhibits epidermal DNA synthesis. Arch Dermatol. 1973;107:861–865
  20. Wenk J, Brenneisen P, Meewes C, et al. UV-induced oxidative stress and photoaging. Curr Probl Dermatol. 2001;29:83–94
  21. Kostovic K, Pasic A. Phototherapy of psoriasis: review and update. Acta Dermatovenerol Croat. 2004;12:42–50
  22. Gonzalez E. PUVA for psoriasis. Dermatol Clin. 1995;13:851–866
  23. Bos JD, de Rie MA, Teunissen MB, Piskin G. Psoriasis: dysregulation of innate immunity. Br J Dermatol. 2005;152:1098–1107
  24. Clark RA, Kupper TS. Misbehaving macrophages in the pathogenesis of psoriasis. J Clin Invest. 2006;116:2084–2087
  25. Stratis A, Pasparakis M, Rupec RA, et al. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest. 2006;116:2094–2104
  26. Wang H, Peters T, Kess D, et al. Activated macrophages are essential in a murine model for T cell–mediated chronic psoriasiform skin inflammation. J Clin Invest. 2006;116:2105–2114
  27. Fierlbeck G, Rassner G, Muller C. Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. Arch Dermatol. 1990;126:351–355
  28. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol. 1999;113:752–759
  29. Ozawa M, Aiba S. Immunopathogenesis of psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3:137–144
  30. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol. 1994;96:146–151
  31. Jacob SE, Nassiri M, Kerdel FA, Vincek V. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators Inflamm. 2003;12:309–313
  32. Bonifati C, Carducci M, Cordiali P, et al. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients—relationships with disease severity. Clin Exp Dermatol. 1994;19:383–387
  33. Kagen MH, McCormick TS, Cooper KD. Regulatory T cells in psoriasis. Ernst Schering Res Found Workshop. 2006;193–209
  34. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest. 1995;95:317–327
  35. Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol. 1999;140:995–1009
  36. Sethi G, Sodhi A. Role of p38 mitogen-activated protein kinase and caspases in UV-B–induced apoptosis of murine peritoneal macrophages. Photochem Photobiol. 2004;79:48–54
  37. Krueger JG, Wolfe JT, Nabeya RT, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med. 1995;182:2057–2068
  38. Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med. 1999;189:711–718
  39. Okamoto H, Horio T, Maeda M. Alteration of lymphocyte functions by 8-methoxypsoralen and long-wave ultraviolet radiation. II. The effect of in vivo PUVA on IL-2 production. J Invest Dermatol. 1987;89:24–26
  40. Aubin F, Mousson C. Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance?. Transplantation. 2004;77(1 Suppl):S29–S31
  41. Kripke ML, Morison WL, Parrish JA. Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA). J Invest Dermatol. 1983;81:87–92
  42. Kasahara S, Aizawa K, Okamiya M, et al. UVB irradiation suppresses cytokine production and innate cellular immune functions in mice. Cytokine. 2001;14:104–111
  43. Weitzen ML, Bonavida B. Mechanism of inhibition of human natural killer activity by ultraviolet radiation. J Immunol. 1984;133:3128–3132
  44. Schneider LA, Bloch W, Kopp K, et al. 8-Isoprostane is a dose-related biomarker for photo-oxidative ultraviolet (UV) B damage in vivo: a pilot study with personal UV dosimetry. Br J Dermatol. 2006;154:1147–1154
  45. Potten CS, Chadwick CA, Cohen AJ, et al. DNA damage in UV-irradiated human skin in vivo: automated direct measurement by image analysis (thymine dimers) compared with indirect measurement (unscheduled DNA synthesis) and protection by 5-methoxypsoralen. Int J Radiat Biol. 1993;63:313–324
  46. Greinert R, Boguhn O, Harder D, Breitbart EW, Mitchell DL, Volkmer B. The dose dependence of cyclobutane dimer induction and repair in UVB-irradiated human keratinocytes. Photochem Photobiol. 2000;72:701–708
  47. Brenneisen P, Blaudschun R, Gille J, et al. Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. Biochem J. 2003;369(Pt 2):341–349
  48. Diffey BL. Towards optimal regimens for the UVB phototherapy of psoriasis: a mathematical model. Acta Derm Venereol. 2004;84:259–264
  49. Zanolli M. Phototherapy arsenal in the treatment of psoriasis. Dermatol Clin. 2004;22:397–406
  50. Parrish JA. Phototherapy of skin diseases. In:  Regan JD,  Parrish JA editor. The science of photomedicine. New York: Plenum Press; 1982;p. 511–531
  51. Kudish AI, Abels D, Harari M. Ultraviolet radiation properties as applied to photoclimatherapy at the Dead Sea. Int J Dermatol. 2003;42:359–365
  52. Snellman E, Lauharanta J, Reunanen A, et al. Effect of heliotherapy on skin and joint symptoms in psoriasis: a 6-month follow-up study. Br J Dermatol. 1993;128:172–177
  53. van Weelden H, De La Faille HB, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119:11–19
  54. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy—an effective treatment for psoriasis. Br J Dermatol. 1988;119:691–696
  55. Karvonen J, Kokkonen EL, Ruotsalainen E. 311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol. 1989;69:82–85
  56. Storbeck K, Holzle E, Schurer N, Lehmann P, Plewig G. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol. 1993;28(2 Pt 1):227–231
  57. Picot E, Picot-Debeze MC, Meunier L, Peyron JL, Meynadier J. Narrow-band UVB phototherapy (Philips TL01 lamps) in psoriasis. Ann Dermatol Venereol. 1992;119:639–642
  58. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. Arch Dermatol. 1999;135:519–524
  59. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol. 2001;45:487–498[quiz 499-502]
  60. Karrer S, Eholzer C, Ackermann G, Landthaler M, Szeimies RM. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches. Dermatology. 2001;202:108–115
  61. Wainwright NJ, Dawe RS, Ferguson J. Narrowband ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen?. Br J Dermatol. 1998;139:410–414
  62. Lui H. Phototherapy of psoriasis: update with practical pearls. J Cutan Med Surg. 2002;6(3 Suppl):17–21
  63. Guideline. An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996). Br J Dermatol. 1997;137:327–330
  64. Cameron H, Dawe RS, Yule S, Murphy J, Ibbotson SH, Ferguson J. A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis. Br J Dermatol. 2002;147:973–978
  65. Markham T, Rogers S, Collins P. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen–UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol. 2003;139:325–328
  66. Penven K, Leroy D, Verneuil L, Faguer K, Dompmartin A. Evaluation of vaseline oil applied prior to UVB TL01 phototherapy in the treatment of psoriasis. Photodermatol Photoimmunol Photomed. 2005;21:138–141
  67. Gordon PM, Diffey BL, Matthews JN, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol. 1999;41(5 Pt 1):728–732
  68. Leenutaphong V, Nimkulrat P, Sudtim S. Comparison of phototherapy two times and four times a week with low doses of narrow-band ultraviolet B in Asian patients with psoriasis. Photodermatol Photoimmunol Photomed. 2000;16:202–206
  69. Dawe RS, Wainwright NJ, Cameron H, Ferguson J. Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment?. Br J Dermatol. 1998;138:833–839
  70. Morison WL. Phototherapy and photochemotherapy: an update. Semin Cutan Med Surg. 1999;18:297–306
  71. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study. Cancer. 1994;73:2759–2764
  72. Lee E, Koo J, Berger T. UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol. 2005;44:355–360
  73. Henseler T, Wolff K, Honigsmann H, Christophers E. Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres. Lancet. 1981;1:853–857
  74. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol. 1977;68:328–335
  75. Guideline. British Photodermatology Group guidelines for PUVA. Br J Dermatol. 1994;130:246–255
  76. Koo J. Psoriasis symposium. Phototherapy. Semin Dermatol. 1992;11(4 Suppl 1):11–16
  77. Sakuntabhai A, Sharpe GR, Farr PM. Response of psoriasis to twice weekly PUVA. Br J Dermatol. 1993;128:166–171
  78. Stern RS. Malignant melanoma in patients treated for psoriasis with PUVA. Photodermatol Photoimmunol Photomed. 1999;15:37–38
  79. Wolff K. Should PUVA be abandoned?. N Engl J Med. 1997;336:1090–1091
  80. Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med. 1998;339:1247–1248
  81. Hannuksela M, Karvonen J. Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis. Br J Dermatol. 1978;99:703–707
  82. Gawlik C, Gibis B, Sander G, Rheinberger P. Usefulness and necessity of unsynchronized photosolotherapy and bath-PUVA—two variants of balneophototherapy—in funded ambulatory health care. Z Arztl Fortbild Qualitatssich. 2001;95:509–512
  83. Halpern SM, Anstey AV, Dawe RS, et al. Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group. Br J Dermatol. 2000;142:22–31
  84. Streit V, Wiedow O, Christophers E. Treatment of psoriasis with polyethylene sheet bath PUVA. J Am Acad Dermatol. 1996;35(2 Pt 1):208–210
  85. Khare S. British Association of Dermatologists annual meeting. Edinburgh, United Kingdom, 29 June-3 July 1999. Abstracts. Br J Dermatol. 1999;141(Suppl 55):114
  86. Berne B, Fischer T, Michaelsson G, Noren P. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients. Photodermatol. 1984;1:18–22
  87. Hannuksela-Svahn A, Sigurgeirsson B, Pukkala E, et al. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol. 1999;141:497–501
  88. Shephard SE, Panizzon RG. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy. Dermatology. 1999;199:106–112
  89. Lebwohl M, Drake L, Menter A, et al. Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol. 2001;45:544–553
  90. Ruzicka T, Sommerburg C, Braun-Falco O, et al. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis. Arch Dermatol. 1990;126:482–486
  91. Lowe NJ, Prystowsky JH, Bourget T, Edelstein J, Nychay S, Armstrong R. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol. 1991;24:591–594
  92. Meola T, Soter NA, Lim HW. Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? A review of the literature. Arch Dermatol. 1991;127:1708–1713
  93. Morison WL, Parrish JA, Fitzpatrick TB. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis. Br J Dermatol. 1978;98:125–132
  94. Schmoll M, Henseler T, Christophers E. Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis. Br J Dermatol. 1978;99:693–702
  95. Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet. 2001;358:1042–1045
  96. Schempp CM, Dittmar HC, Hummler D, et al. Magnesium ions inhibit the antigen-presenting function of human epidermal Langerhans cells in vivo and in vitro. Involvement of ATPase, HLA-DR, B7 molecules, and cytokines. J Invest Dermatol. 2000;115:680–686
  97. Schempp CM, Muller K, Schulte-Monting J, Schopf E, Simon JC. Salt water bathing prior to UVB irradiation leads to a decrease of the minimal erythema dose and an increased erythema index without affecting skin pigmentation. Photochem Photobiol. 1999;69:341–344
  98. Schiffner R, Schiffner-Rohe J, Wolfl G, et al. Evaluation of a multicentre study of synchronous application of narrowband ultraviolet B phototherapy (TL-01) and bathing in Dead Sea salt solution for psoriasis vulgaris. Br J Dermatol. 2000;142:740–747
  99. Feldman SR. Remissions of psoriasis with excimer laser treatment. Dermatol Online J. 2002;8:23
  100. Gerber W, Arheilger B, Ha TA, Hermann J, Ockenfels HM. Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach. Br J Dermatol. 2003;149:1250–1258
  101. Kollner K, Wimmershoff MB, Hintz C, Landthaler M, Hohenleutner U. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Br J Dermatol. 2005;152:750–754
  102. Smits T, Kleinpenning MM, van Erp PE, van de Kerkhof PC, Gerritsen MJ. A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid–photodynamic therapy in patients with psoriasis. Br J Dermatol. 2006;155:429–436
  103. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clin Exp Dermatol. 2004;29:560–562
  104. Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, et al. Topical aminolaevulinic acid–based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol. 2005;152:279–283
  105. Langan SM, Heerey A, Barry M, Barnes L. Cost analysis of narrowband UVB phototherapy in psoriasis. J Am Acad Dermatol. 2004;50:623–626
  106. Hazard E, Cherry SB, Lalla D, Woolley JM, Wilfehrt H, Chiou CF. Clinical and economic burden of psoriasis. Manag Care Interface. 2006;19:20–26
  107. Feldman SR, Fleischer AB, Reboussin DM, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol. 1997;37:564–569
  108. Miller DW, Feldman SR. Cost-effectiveness of moderate-to-severe psoriasis treatment. Expert Opin Pharmacother. 2006;7:157–167
  109. Lim C, Brown P. Quality of life in psoriasis improves after standardized administration of narrowband UVB phototherapy. Australas J Dermatol. 2006;47:37–40
  110. Callen JP, Krueger GG, Lebwohl M, et al. AAD consensus statement on psoriasis therapies. J Am Acad Dermatol. 2003;49:897–899
  111. Guenther L, Langley RG, Shear NH, et al. Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004. J Cutan Med Surg. 2004;8:321–337
  112. Sterry W, Barker J, Boehncke WH, et al. Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol. 2004;151(Suppl 69):3–17
  113. Feldman SR. The psoriasis and psoriatic arthritis pocket guide: treatment algorithms and management options. Portland (Ore): National Psoriasis Foundation; 2005;
  114. Richards HL, Fortune DG, Griffiths CE. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol. 2006;20:370–379
  115. Morison WL. Variations of PUVA: practical and effective?. Arch Dermatol. 1998;134:1286–1288

PII: S0738-081X(07)00264-7

doi: 10.1016/j.clindermatol.2007.11.004

Clinics in Dermatology
Volume 26, Issue 5 , Pages 464-476 , September 2008

Article Tools

* Image Usage & Resolution